MedCity News » medical devices

FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy. The post FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes appeared first on MedCity News.

Feb 9, 2025 - 22:03
 0
FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.

The post FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes appeared first on MedCity News.

Read More

Tags:

Previous Article

How Medicare Coverage Diversifies Access to Innovation

Next Article

Here’s a Preview of the Startups Pitching in the Medical Device Track at MedCity...

Related Posts

The Dangerous Cycle of Anxiety and Diabetes

The Dangerous Cycle of Anxiety and Diabetes

Feb 9, 2025  0

Wearable Tech is Empowering Patients To Be Proactive in Their Health

Wearable Tech is Empowering Patients To Be Proactive in...

Feb 9, 2025  0

MedCity Pivot: A Conversation About Wearable Robots with Scott Davis

MedCity Pivot: A Conversation About Wearable Robots wit...

Feb 9, 2025  0